Instil Bio TIL
NASDAQ TIL
$7.40 -0.11 (-1.46%)
As of: Sep 10, 2026 · 3:17 PM EDT

Instil Bio (TIL) Other Operating Expenses (2024 - 2026)

Instil Bio (TIL) posted Other Operating Expenses of $1.6 million for Q1 2026, down 83.8% on a QoQ basis from $10.0 million in Q3 2024.

Analysis

Instil Bio (TIL) Other Operating Expenses (2024 - 2026) Analysis & Trends

Instil Bio has reported Other Operating Expenses for 2 years, with the latest figure at $1.6 million in Q1 2026.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $1.6 million in Q1 2026; TTM through Jun 2026 was $1.6 million, a 83.8% decrease from a year earlier, with the FY2025 full-year figure at $10.0 million, changed 0.0% from the prior year.
  • Other Operating Expenses was $1.6 million for Q1 2026 at Instil Bio, down from $10.0 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $10.0 million in Q3 2024, with the low at $1.6 million in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Instil Bio 50.19 Mn 50.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.62 Mn
Sep 30, 2024 10.00 Mn